Withdrawal symptoms in neonates from intrauterine exposure to diazepam.
Three infants are presented who had withdrawal symptoms after prolonged, intrauterine exposure to diazepam. Symptoms, clinical course, management, and laboratory findings are described. Some physiologic aspects of diazepam in the fetus and neonate are discussed. One infant died at six weeks of age; death was attributed to the sudden infant death syndrome.
D003975:Diazepam / Q000009:adverse effects*; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D008297:Male; D010634:Phenobarbital / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy
D003975:Diazepam; D010634:Phenobarbital